The DOI matches its Crossref record; 769 of the 769 references it cites were found in a registry or an index.
Nuclear Receptors and Their Selective Pharmacologic Modulators
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 601–769 of 769
Francis, G. A., Li, G., Casey, R. E., Wang, J., Cao, H., Leff, T., & Hegele, R. A. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-3 · Cited by 64
Daniel, C., Radeke, H. H., Sartory, N. A., Zahn, N., Züegel, U., Steinmeyer, A., & Stein, J. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107599 · Cited by 64
A Natural Product Ligand of the Oxysterol Receptor, Liver X Receptor
Bramlett, K. S., Houck, K. A., Borchert, K. M., Dowless, M. S., Kulanthaivel, P., Zhang, Y., Beyer, T. P., Schmidt, R., Thomas, J. S., Michael, L. F., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052852 · Cited by 63
Self-citationSjöberg, M., & Vennström, B. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4718 · Cited by 63
Zhao, W., Wang, L., Zhang, M., Wang, P., Zhang, L., Yuan, C., Qi, J., Qiao, Y., Kuo, P. C., & Gao, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149823 · Cited by 62
1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation.
Adorini, L. (2002) · PubMed · Cited by 62
Wan, W., Farboud, B., & Privalsky, M. L. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0014 · Cited by 61
Richardson, A. R., & Maltz, F. N. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.012 · Cited by 61
Jones, A. J., Chen, J., Hwang, D., Miller, D. D., & Dalton, J. T. (2008) · Endocrinology · doi:10.1210/en.2008-0674 · Cited by 61
Chwalisż, K., Elger, W. A. G., Stickler, T., Mattia‐Goldberg, C., & Larsen, L. M. (2005) · Human Reproduction · doi:10.1093/humrep/deh738 · Cited by 61
Shafiee, A., Bucolo, C., Budzynski, E., Ward, K. W., & López, F. J. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5598 · Cited by 60
KR-62980: A novel peroxisome proliferator-activated receptor γ agonist with weak adipogenic effects
Kim, K. R., Lee, J. H., Kim, S. J., Rhee, S. D., Jung, W. H., Yang, S., Kim, S. S., Ahn, J. H., & Cheon, H. G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.05.005 · Cited by 60
The 2.0 Å crystal structure of the ERα ligand‐binding domain complexed with lasofoxifene
Vajdos, F. F., Hoth, L. R., Geoghegan, K. F., et al. (2007) · Protein Science · doi:10.1110/ps.062729207 · Cited by 60
Cao, G., Bales, K., DeMattos, R., & Paul, S. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362173 · Cited by 60
Rendi, M. H., Suh, N., Lamph, W. W., Krajewski, S., Reed, J. C., Heyman, R. A., Berchuck, A., Liby, K. T., Risingsong, R., Royce, D. B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0234 · Cited by 60
Jayasuriya, H., Herath, K. B., Ondeyka, J. G., Guan, Z., Borris, R. P., Tiwari, S., de Jong, W., Chavez, F., Moss, J., Stevenson, D. W., et al. (2005) · Journal of Natural Products · doi:10.1021/np050182g · Cited by 59
Liby, K. T., Rendi, M. H., Suh, N., Royce, D. B., Risingsong, R., Williams, C. R., Lamph, W. W., Labrie, F., Krajewski, S., Xu, X., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1119 · Cited by 59
Structure-Activity Relationship of Nuclear Receptor-Ligand Interactions
Greschik, H., & Moras, D. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033451736 · Cited by 58
Eggert, M., Möws, C. C., TRIPIER, D., Arnold, R., Michel, J. F., Nickel, J., Schmidt, S., Beato, M., & Renkawitz, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30755 · Cited by 58
Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease
Bregenholtant, S., & Claësson, M. H. (1998) · European Journal of Immunology · Cited by 58
Calcipotriol: A New Drug for Topical Psoriasis Treatment
Kragballe, K. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb01020.x · Cited by 58
Fabian, C., Kimler, B., Anderson, J., Tawfik, O., Mayo, M., Burak, W., O'Shaughnessy, J., Albain, K., Hyams, D., Budd, G., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0171 · Cited by 58
Nishishita, T., Okazaki, T., Ishikawa, T., Igarashi, T., Hata, K., Ogata, E., & Fujita, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.10901 · Cited by 57
Glasier, A. F. (1990) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(05)80306-2 · Cited by 57
Tanaka, Y., Nakamura, T., Nishida, S., Suzuki, K., Takeda, S., Sato, K., & Nishii, Y. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110306 · Cited by 57
Analysis of glucocorticoid signalling by gene targeting
Reichardt, H. M., Kaestner, K. H., Wessely, O., Gass, P., Schmid, W., & Schütz, G. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00181-7 · Cited by 57
Wiebel, F. F., & Gustafsson, J.-Α. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3977 · Cited by 56
Koldamova, R., & Lefterov, I. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362227 · Cited by 56
Cavet, M. E., Harrington, K. L., Ward, K. W., & Zhang, J.-Z. (2010) · PubMed Central · Cited by 56
The immninent dawn of SPRMs in obstetrics and gynecology
Chabbert‐Buffet, N., Pintiaux, A., & Bouchard, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.021 · Cited by 55
Pochetti, G., Mitro, N., Lavecchia, A., Gilardi, F., Bešker, N., Scotti, E., Aschi, M., Re, N., Fracchiolla, G., Laghezza, A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm9013899 · Cited by 55
Rangwala, S. M., & Lazar, M. A. (2002) · Science Signaling · doi:10.1126/stke.2002.121.pe9 · Cited by 55
Trost, S. U. (2000) · Endocrinology · doi:10.1210/en.141.9.3057 · Cited by 55
Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
Lewis, J. D., Chagpar, A. B., Shaughnessy, E., Nurko, J., McMasters, K. M., & Edwards, M. J. (2010) · Cancer · doi:10.1002/cncr.24940 · Cited by 54
Ciesielski, F., Rochel, N., Mitschler, A., Kouzmenko, A., & Moras, D. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.03.109 · Cited by 54
Liver X receptor modulators: a review of recently patented compounds (2007 – 2009)
Li, X., Yeh, V. S. C., & Molteni, V. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543771003621269 · Cited by 54
Acton, J. J., Akiyama, T. E., Chang, C. H., Colwell, L. F., Debenham, S. D., Doebber, T. W., Einstein, M., Liu, K., McCann, M. E., Moller, D. E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900097m · Cited by 53
Tancevski, I., Demetz, E., Eller, K., Duwensee, K., Hoefer, J., Heim, C., Stanzl, U., Wehinger, A., Auer, K., Karer, R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008722 · Cited by 53
Folding of the glucocorticoid receptor N-terminal transactivation function: Dynamics and regulation
Kumar, P., & Thompson, E. B. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.03.024 · Cited by 53
Receptor Isoforms That Mediate Estrogen and Progestagen Action in the Female Lower Urinary Tract
Tincello, D. G., Taylor, A. H., Spurling, S. M., & Bell, S. C. (2009) · The Journal of Urology · doi:10.1016/j.juro.2008.10.104 · Cited by 53
LGD-5552, an Antiinflammatory Glucocorticoid Receptor Ligand with Reduced Side Effects, in Vivo
LÓPEZ, F. J., Ardecky, R., Bebo, B. F., Benbatoul, K. D., de Grandpre, L. Y., Liu, S., Leibowitz, M. D., Marschke, K. B., Rosen, J., Rungta, D. K., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1353 · Cited by 53
Chao, E. Y. H., Caravella, J. A., Watson, M. A., Campobasso, N., Ghisletti, S., Billin, A. N., Galardi, C. M., Wang, P., Laffitte, B. A., Iannone, M. A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800612u · Cited by 53
Schafer, J. M., Lee, E. S., Dardes, R. C., Bentrem, D. J., O'Regan, R. M., Reyes, A. D. L., & Jordan, V. C. (2001) · PubMed · Cited by 52
Mansel, R. E., Goyal, A., Nestour, E. L., Masini-Etévé, V., & White, K. O. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9507-x · Cited by 52
Characterization of Iodothyronine Sulfatase Activities in Human and Rat Liver and Placenta
Kester, M. H. A., Kaptein, E., van Dijk, C. H., Roest, T. J., Tibboel, D., Coughtrie, M. W. H., & Visser, T. J. (2002) · Endocrinology · doi:10.1210/endo.143.3.8686 · Cited by 52
Chlon, T. M., Taffany, D. A., Welsh, J., & Rowling, M. J. (2008) · Journal of Nutrition · doi:10.1093/jn/138.7.1323 · Cited by 51
The Isolation in Crystalline Form of the Compound Containing Iodin, Which Occurs in the Thyroid
Kendall, E. C. (1983) · JAMA · doi:10.1001/jama.1983.03340150087037 · Cited by 51
DiBlasio-Smith, E. A., Arai, M., Quinet, E. M., Evans, M. J., Kornaga, T., Basso, M., Chen, L., Feingold, I. B., Halpern, A. R., Liu, Q.-Y., et al. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-59 · Cited by 51
Lavigne, A.-C., Mengus, G., Gangloff, Y., Wurtz, J., & Davidson, I. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5486 · Cited by 51
Takeuchi, Y., Murata, Y., Sadow, P. M., Hayashi, Y., Seo, H., Xu, J., O’Malley, B. W., Weiss, R. E., & Refetoff, S. (2002) · Endocrinology · doi:10.1210/endo.143.4.8730 · Cited by 50
Zhang, S., Liang, X., & Danielsen, M. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.1.8838142 · Cited by 50
Chwalisż, K., DeManno, D. A., Garg, R. C., Larsen, L. M., Mattia‐Goldberg, C., & Stickler, T. (2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-828617 · Cited by 50
Patterns of Liver Gene Expression Governed by TR
Flores‐Morales, A. (2002) · Molecular Endocrinology · doi:10.1210/me.16.6.1257 · Cited by 50
Luo, X., Yin, P., V., J. S. C., Cheng, Y.-H., Wiehle, R. D., & Bulun, S. E. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.11.031 · Cited by 49
Control of Secondary Hyperparathyroidism by Vitamin D Receptor Agonists in Chronic Kidney Disease
Sprague, S. M., & Coyne, D. W. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03850609 · Cited by 49
Tomita, T., Kakiuchi, Y., & Tsao, P. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1856 · Cited by 48
LONG-TERM EFFECT OF DRIED THYROID ON SERUM-LIPOPROTEIN AND SERUM-CHOLESTEROL LEVELS
Gofman, J., Strisower, B., Rubinger, J. H., Guzvich, P., Galioni, E. F., & Pouteau, J. (1957) · The Lancet · doi:10.1016/s0140-6736(57)90199-x · Cited by 48
Factors Altering Thyroid Hormone Metabolism
Robbins, J. (1981) · Environmental Health Perspectives · doi:10.1289/ehp.813865 · Cited by 48
Serum high-density lipoprotein cholesterol concentrations in hypo- and hyperthyroidism.
Scottolini, A. G., Bhagavan, N. V., Oshiro, T. H., & Abe, S. Y. (1980) · Clinical Chemistry · doi:10.1093/clinchem/26.5.584 · Cited by 48
Hz, K. (1998) · Endocrinology · doi:10.1210/en.139.4.2068 · Cited by 48
Sherman, S., & Ladenson, P. (1992) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.75.3.1517383 · Cited by 47
Designing the ideal selective estrogen receptor modulator-an achievable goal?
Taylor, H. S. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181906fa3 · Cited by 46
Sato, M., Zeng, G. Q., Rowley, E. R., & Turner, C. H. (1998) · Endocrinology · doi:10.1210/endo.139.11.6307 · Cited by 46
Li, Y., Bryant, H. U., Zeng, Q., Palkowitz, A. D., Jee, W. S. S., Turner, C. H., & Sato, M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.12.2256 · Cited by 46
Camp, H. S. (1999) · Endocrinology · doi:10.1210/en.140.1.392 · Cited by 46
Amuchastegui, S., Daniel, K. C., & Adorini, L. (2005) · Transplantation · doi:10.1097/01.tp.0000164619.49828.7a · Cited by 45
Resistance to Thyroid Hormone: An Historical Overview
Refetoff, S. (1994) · Thyroid · doi:10.1089/thy.1994.4.345 · Cited by 45
Peleg, S., Uskoković, M. R., Ahene, A. B., VICKERY, B. H., & Avnur, Z. (2002) · Endocrinology · doi:10.1210/endo.143.5.8777 · Cited by 45
Nonsteroidal Selective Androgen Receptor Modulator Ostarine ™ in Cancer Cachexia
Zilbermint, M. F., & Dobs, A. S. (2009) · Future Oncology · doi:10.2217/fon.09.106 · Cited by 45
L-Thyroxine contamination of pharmaceutical D-thyroxine: Probable cause of therapeutic effect
Young, W. F., Gorman, C. A., Jiang, N.-S., Machacek, D., & Hay, I. D. (1984) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1984.257 · Cited by 45
On Sporadic Cretinism in America
Osler, W. (1893) · The American Journal of the Medical Sciences · doi:10.1097/00000441-189311000-00001 · Cited by 44
Stephan, Z. F., Yurachek, E. C., Sharif, R., Wasvary, J. M., Steele, R. E., & Howes, C. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90640-5 · Cited by 44
Günther, C., Kecskes, A., Staks, T., & Täuber, U. (1998) · Skin Pharmacology and Physiology · doi:10.1159/000029806 · Cited by 44
Modulation of liver X receptor signaling as a prevention and therapy for colon cancer
Chuu, C. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.01.037 · Cited by 44
Barry, J. B., Leong, G. M., Church, W. B., Issa, L. L., Eisman, J. A., & Gardiner, E. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200712200 · Cited by 44
Ito, B., Zhang, B. L., Cable, E. E., Song, X., Fujitaki, J., MacKenna, D., Wilker, C., Chi, B., Poelje, P. V., Linemeyer, D., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1750-3639.2009.00038.x · Cited by 44
Petit-Topin, I., Turque, N., Fagart, J., Fay, M., Ulmann, A., Gainer, E., & Rafestin-Oblin, M. E. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054312 · Cited by 44
PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study.
Erdmann, E., Dormandy, J., Wilcox, R., Massi‐Benedetti, M., & Charbonnel, B. H. (2007) · PubMed Central · Cited by 43
Rochefort, H., Garcia, M., & Borgna, J. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)92055-2 · Cited by 43
Genetic Manipulations of PPARs: Effects on Obesity and Metabolic Disease
Barak, Y., & Kim, S. (2007) · PPAR Research · doi:10.1155/2007/12781 · Cited by 43
Wiehle, R. D., Lantvit, D. D., Yamada, T., & Christov, K. T. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0244 · Cited by 43
Grover, G. J., Mellström, K., & Malm, J. (2007) · Current Vascular Pharmacology · doi:10.2174/157016107780368271 · Cited by 43
Miner, J. N. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01121-8 · Cited by 43
Tamoxifen to raloxifene and beyond
O'Regan, R. M., & Jordan, V. C. (2001) · Seminars in Oncology · doi:10.1053/sonc.2001.23492 · Cited by 42
Vergote, I. B., & Robertson, J. F. R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601631 · Cited by 41
Herrlich, P. A., & Ponta, H. (1994) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)90164-3 · Cited by 41
Investigational PPAR-γ agonists for the treatment of Type 2 diabetes
Savkur, R. S., & Miller, A. R. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.763 · Cited by 40
Liver X receptors as therapeutic targets in metabolism and atherosclerosis
Nomiyama, T., & Bruemmer, D. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0013-3 · Cited by 40
Wiebel, F. F., Steffensen, K. R., Treuter, E., Feltkamp, D., & Gustafsson, J.-Α. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.7.0292 · Cited by 40
Progesterone Receptor Antagonists and the Endometrial Antiproliferative Effect
Brenner, R., & Slayden, O. D. (2005) · Seminars in Reproductive Medicine · doi:10.1055/s-2005-864035 · Cited by 40
Gullberg, H. (2000) · Molecular Endocrinology · doi:10.1210/me.14.11.1739 · Cited by 40
Structural Determinants of Selective Thyromimetics
Yoshihara, H. A. I., Apriletti, J. W., Baxter, J. D., & Scanlan, T. S. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0301181 · Cited by 39
Fujimura, T., Sakuma, H., Konishi, S., Oe, T., Hosogai, N., Kimura, C., Aramori, I., & Mutoh, S. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050578 · Cited by 39
Review of the unique properties of budesonide
O’Connell, E. J. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80305-3 · Cited by 39
SEGRAs: A Novel Class of Anti-inflammatory Compounds
Schäcke, H., Hennekes, H., Schottelius, A. J. G., Jaroch, S., Lehmann, M., Schmees, N., Rehwinkel, H., & Asadullah, K. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_20 · Cited by 38
The multifunctional estrogen receptor-alpha F domain
Skafar, D. F., & Zhao, C. (2008) · Endocrine · doi:10.1007/s12020-008-9054-1 · Cited by 38
LAVERNY, G., Penna, G., Uskoković, M. R., Marczak, S., Maehr, H., Jankowski, P., Flarakos, C. C., Vouros, P., Smith, B., Robinson, M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801365a · Cited by 38
Peleg, S., Ismail, A., Uskoković, M. R., & Avnur, Z. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10344 · Cited by 38
Augmentation of PPARγ-TAZ interaction contributes to the anti-adipogenic activity of KR62980
Jung, H., Lee, M. S., Jang, E. J., Ahn, J. H., Kang, N. S., Yoo, S.-E., Bae, M. A., Hong, J., & Hwang, E. S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.001 · Cited by 37
The cure of infantile rickets by artificial light and by sunlight
HESS, A. F., & Unger, L. J. (1921) · Experimental Biology and Medicine · doi:10.3181/00379727-18-153 · Cited by 37
Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats
Komm, B. S., Vlasseros, F., Samadfam, R., Chouinard, L., & Smith, S. Y. (2011) · Bone · doi:10.1016/j.bone.2011.05.024 · Cited by 36
TSH Regulation Dynamics in Central and Extreme Primary Hypothyroidism
Eisenberg, M. C., Santini, F., Marsili, A., Pinchera, A., & DiStefano, J. J. (2010) · Thyroid · doi:10.1089/thy.2009.0349 · Cited by 36
Arzoxifene as therapy for endometrial cancer
Burke, T. W., & Walker, C. L. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00343-3 · Cited by 36
Amita, M., Takahashi, T., Tsutsumi, S., Ohta, T., Takata, K., Henmi, N., Hara, S., Igarashi, H., Takahashi, K., & Kurachi, H. (2009) · Endocrinology · doi:10.1210/en.2009-0721 · Cited by 36
Minoura, H., Takeshita, S., Kimura, C., Hirosumi, J., Takakura, S., Kawamura, I., Seki, J., Manda, T., & Mutoh, S. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00619.x · Cited by 36
Carballo‐Jane, E., Pandit, S., Santoro, J. C., Freund, C. M., Luell, S., Harris, G., Forrest, M. J., & Sitlani, A. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.11.012 · Cited by 36
DeLuca, H. F., Bedale, W. A., Binkley, N., Gallagher, J. C., Bolognese, M. A., Peacock, M., Aloia, J. F., Clagett‐Dame, M., & Plum, L. A. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.256 · Cited by 35
Ng, L., Forrest, D., Haugen, B. R., Wood, W. M., & Curran, T. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.9.7491112 · Cited by 35
Minoura, H., Takeshita, S., Yamamoto, T. S., Mabuchi, M., Hirosumi, J., Takakura, S., Kawamura, I., Seki, J., Manda, T., Ita, M., et al. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.05.042 · Cited by 35
PHYSIOLOGIC ACTIVITY OF TRIIODO- AND TETRAIODOTHYROACETIC ACID IN HUMAN MYXEDEMA*†
Lerman, J., & Pitt‐Rivers, R. (1956) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-16-11-1470 · Cited by 35
Fujimura, T., Kimura, C., Oe, T., Takata, Y., Sakuma, H., Aramori, I., & Mutoh, S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102459 · Cited by 35
The thyromimetic T-0681 protects from atherosclerosis
Tancevski, I., Wehinger, A., Demetz, E., Hoefer, J., Eller, K., Huber, E., Stanzl, U., Duwensee, K., Auer, K., Schgoer, W., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800553-jlr200 · Cited by 34
Target specificity of selective estrogen receptor modulators within human endometrial cancer cells
Bramlett, K. S., & Burris, T. P. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00258-9 · Cited by 34
Self-citationLuteal phase dose-response relationships of the antiprogestin CDB-2914 in normally cycling women
Passaro, M. (2003) · Human Reproduction · doi:10.1093/humrep/deg342 · Cited by 34
Sottili, M., Cosmi, L., Borgogni, E., Sarchielli, E., Maggi, L., Francalanci, M., Vannelli, G. B., Ronconi, E., Adorini, L., Annunziato, F., et al. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.10.025 · Cited by 34
Future use of clomiphene in ovarian stimulation. Will clomiphene persist in the 21st century?
Tarlatzis, B. C., & Grimbizis, G. (1998) · Human Reproduction · doi:10.1093/humrep/13.9.2356 · Cited by 33
Vajda, E. G., LÓPEZ, F. J., Rix, P. J., Hill, R., Chen, Y., Lee, K., O’Brien, Z., Chang, W. Y., Meglasson, M. D., & Lee, Y.-H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146811 · Cited by 33
Wang, X., Simmons, H. A., Salatto, C. T., Cosgrove, P. G., & Thompson, D. D. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000227337.73738.c9 · Cited by 32
Han, Y., Feng, H. L., Sandlow, J. I., & Haines, C. J. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.005157 · Cited by 32
Bundred, N. J., Anderson, E., Nicholson, R. I., Dowsett, M., Dixon, J. M., & Robertson, J. F. R. (2002) · PubMed · Cited by 32
Steroidal and Triterpenoidal Fungal Metabolites as Ligands of Liver X Receptors
Ondeyka, J. G., Jayasuriya, H., Herath, K. B., Guan, Z., Schulman, M., Collado, J., Dombrowski, A. W., Kwon, S. S., McCallum, C. D., Sharma, N., et al. (2005) · The Journal of Antibiotics · doi:10.1038/ja.2005.76 · Cited by 30
Glucocorticoids Pharmacology: Past, Present and Future
Gessi, S., Merighi, S., & Borea, P. A. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793797915 · Cited by 29
Kurosawa, T., Hiroi, H., Momoeda, M., Inoue, S., & Taketani, Y. (2010) · Endocrine Journal · doi:10.1507/endocrj.k09e-368 · Cited by 28
Chlebowski, R. T., Kim, J. A., & Col, N. F. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.021 · Cited by 28
Sharma, M., Aronow, W. S., Patel, L., Gandhi, K., & Desai, H. V. (2011) · Medical Science Monitor · doi:10.12659/msm.881705 · Cited by 28
Fujimura, T., Sakuma, H., Ohkubo‐Suzuki, A., Aramori, I., & Mutoh, S. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.423 · Cited by 27
Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator
Piu, F., Gardell, L. R., Son, T., Schlienger, N., Lund, B. W., Schiffer, H. H., Vanover, K. E., Davis, R. E., Olsson, R., & Bradley, S. R. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.11.001 · Cited by 27
Chang, J., Cha, H., Lee, D., Seo, K. Y., & Kweon, M. (2010) · PLoS ONE · doi:10.1371/annotation/6da7b65e-dda2-467d-bcb3-82d5669f6bc6 · Cited by 27
Resistance to Antiestrogen Arzoxifene Is Mediated by Overexpression of Cyclin D1
Zwart, W. T., Rondaij, M. G., Jalink, K., Sharp, Z. D., Mancini, M. A., Neefjes, J., & Michalides, R. J. A. M. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0268 · Cited by 26
Dey, D., Medicherla, S., Neogi, P., Gowri, M. S., Cheng, J., Gross, C., Sharma, S., Reaven, G. M., & Nag, B. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00152-5 · Cited by 26
Kremoser, C., Albers, M., Burris, T. P., Deuschle, U., & Koegl, M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.025 · Cited by 24
Self-citationMengus, G., Gangloff, Y., Carré, L., Lavigne, A.-C., & Davidson, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10064 · Cited by 23
Role of the musculoskeletal system and the prevention of falls.
Fraix, M. P. (2012) · PubMed · Cited by 22
Barycki, R., Siciński, R. R., Plum, L. A., Grzywacz, P., Clagett‐Dame, M., & DeLuca, H. F. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.09.047 · Cited by 22
Welker, P., Lippert, U., Nürnberg, W., et al. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237208 · Cited by 22
Mechanisms of action of mifepristone when used for emergency contraception
Gemzell‐Danielsson, K., Mandl, I., & Marions, L. (2003) · Contraception · doi:10.1016/s0010-7824(03)00070-2 · Cited by 21
Effects of bazedoxifene in nonflushing postmenopausal women
Bachmann, G. A., Crosby, U., Feldman, R., Ronkin, S., & Constantine, G. D. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181fa358b · Cited by 21
Zhao, H., Lo, Y., Yu, L., & Wang, S. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20721 · Cited by 21
Nemere, I., & Hintze, K. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21437 · Cited by 20
Dreier, R., Günther, B. K., Mainz, T., Nemere, I., & Brückner, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703336200 · Cited by 20
The effect of the new SERM arzoxifene on growth and gene expression in MCF-7 breast cancer cells
Freddie, C. T., Larsen, S. S., Bartholomæussen, M., et al. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.02.003 · Cited by 19
Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammation
Won, H. Y., Min, H. J., Ahn, J. H., Yoo, S.-E., Bae, M. A., Hong, J., & Hwang, E. S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.10.023 · Cited by 18
Kendler, D. L., Palacios, S., Cox, D. A., Stock, J. L., Alam, J., Dowsett, S. A., & Zanchetta, J. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1587-0 · Cited by 18
Morris, D., Podolski, J. S., Kirsch, A., Wiehle, R. D., & Fleckenstein, L. L. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9304-7 · Cited by 18
Sagrinati, C., Sottili, M., Mazzinghi, B., Borgogni, E., Adorini, L., Serio, M., Romagnani, P., & Crescioli, C. (2010) · Transplant International · doi:10.1111/j.1432-2277.2010.01078.x · Cited by 18
Anderson, L. M., Choe, S. E., Yukhananov, R. Y., Hopfner, R. L., Church, G. M., Pratt, R. E., & Dzau, V. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208644200 · Cited by 17
Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonists
Thompson, S. K., Washburn, D. G., Frazee, J. S., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.055 · Cited by 17
Dhawan, B. N., & Srimal, R. C. (1973) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1973.tb08268.x · Cited by 16
Efficacy and safety of bazedoxifene in postmenopausal Asian women
Xu, L., Tsai, K., Kim, G. S., Wu, Y., Vincendon, P., Chines, A. A., & Constantine, G. D. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1259-5 · Cited by 15
Lasofoxifene: Evidence of its therapeutic value in osteoporosis
Gennari, L. (2009) · Core evidence · doi:10.2147/ce.s6001 · Cited by 15
Weinberger, C., Giguère, V., Hollenberg, S. M., Rosenfeld, M. G., & Evans, R. M. (1986) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1986.051.01.089 · Cited by 15
Sato, M. (1998) · Endocrinology · doi:10.1210/en.139.11.4642 · Cited by 15
Kim, K. Y., Cho, H. S., Lee, S. H., Ahn, J. H., & Cheon, H. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.062 · Cited by 14
Daverey, A., Saxena, R., Tewari, S., Goel, S. K., & Dwivedi, A. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.05.006 · Cited by 14
McKenna, N. J., & O’Malley, B. W. (2010) · Cell · doi:10.1016/j.cell.2010.09.032 · Cited by 14
Long, X., Fan, M., & Nephew, K. P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.5.10926 · Cited by 13
New Insights on the Mechanism of PPAR‐targeted Drugs
Grether, U., Klaus, W., Kuhn, B., Maerki, H. P., Mohr, P., & Wright, M. B. (2010) · ChemMedChem · doi:10.1002/cmdc.201000446 · Cited by 13
Pluchino, N., Merlini, S., Cubeddu, A., Giannini, A., Bucci, F., Casarosa, E., Cela, V., Angioni, S. L., Luisi, M., & Genazzani, A. R. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31819b351e · Cited by 13
DT56a (Femarelle) stimulates bone formation in female rats
Sömjen, D., Katzburg, S., Livne, E., & Yoles, I. (2005) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00573.x · Cited by 13
A novel approach to the discovery of non-systemic anti-inflammatory steroids; Antedrug
Lee, H. J., & Ko, D.-H. (1999) · Archives of Pharmacal Research · doi:10.1007/bf02976363 · Cited by 12
Improving the developability profile of pyrrolidine progesterone receptor partial agonists
Kallander, L. S., Washburn, D. G., Hoang, T. H., Frazee, J. S., Stoy, P., Johnson, L., Lu, Q., Hammond, M., Barton, L. S., Patterson, J. R., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.092 · Cited by 11
Schwinn, M. K., & DeLuca, H. F. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.06.015 · Cited by 10
Garas, A., Trypsianis, G. A., Kallitsaris, A., et al. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02093.x · Cited by 7
New and Emerging Therapies for Osteoporosis
Lewiecki, E. M., Díaz Curiel, M., Borges, J. L. C., Kung, A. W. C., Brandi, M. L., & Dimai, H. P. (2010) · Journal of Osteoporosis · doi:10.4061/2010/318320 · Cited by 5
Tamoxifen to raloxifene and beyond
OAPOSREGAN, R. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90119-8 · Cited by 5
Vennström, B., Liu, H., & Forrest, D. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_7 · Cited by 4
Evolving Concepts of Thyroid Function
Bartuska, D. G., & Dratman, M. B. (1973) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)32255-6 · Cited by 4
A new MCF-7 breast cancer cell line resistant to the arzoxifene metabolite desmethylarzoxifene.
Freddie, C. T., Christensen, G. L., & Lykkesfeldt, A. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.03.005 · Cited by 3
Cited by
Targeting transcription factors in cancer — from undruggable to reality
Bushweller, J. H. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0196-7 · Cited by 919
Fleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 544
The nuclear receptor superfamily: A structural perspective
Weikum, E. R., Liu, X., & Ortlund, E. A. (2018) · Protein Science · doi:10.1002/pro.3496 · Cited by 495
Muscle as a “Mediator” of Systemic Metabolism
Baskin, K. K., Winders, B. R., & Olson, E. N. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.021 · Cited by 333
Bile acids in glucose metabolism and insulin signalling — mechanisms and research needs
Ahmad, T. R., & Haeusler, R. A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0266-7 · Cited by 337
Metadata
- Authors
- Burris, T. P., Solt, L. A., Wang, Y., Crumbley, C., Banerjee, S., Griffett, K., Lundasen, T., Hughes, T., & Kojetin, D. J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 65
- Issue
- 2
- Pages
- 710-778
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2110046079
- Cited by
- 283
- References
- 769
- FWCI
- 13.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.